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1  
Abstract 
 
Introduction: Blastocystis hominis is the most common intestinal parasite isolated in humans. However, 
a lot of controversies still surround it. Even it has a worldwide distribution, with a higher prevalence in 
developing countries, its burden is still under-estimated. Nowadays, interest concerning it is increasing due 
to its potential role as a human pathogen. The aim of the study is to detect the risk factors associated to 
Blastocystis hominis infection. 
Materials and Methods: a case-control retrospective study was carried out at Vall d’Hebron University 
Hospital, a reference Hospital that receives all microbiological tests performed in Barcelona at primary care 
level. Eligible patients were those adults in whom with three consecutive stool samples that had been 
examined for parasitic infection diagnosis during 2017. Blagg’s technique (merthiolate-iodine-formaldehyde 
concentration) was used to microscopically examine Blastocystis sp. Medical record review and telephonic 
interviews were carried out in order to gather clinical and epidemiological information. 
Results. Overall, 4174 patients were eligible for the study, from whom 1928 (15.4%) had Blastocystis 
sp. infection. 170 cases (infected) and 170 controls (non-infected) were randomly selected for inclusion. 
Most of the participants were females (60.6%), with a median age of 46.7 (17-88) years. 126 (37.1%) of 
them were immigrants, mostly from America (20.3%), and had been living in Spain for 11 years, on average. 
171 (50.3%) patients had travelled out of Spain the year before the sampling, mostly to European countries 
(19.4%). The majority of individuals had jobs with direct contact with other people (health personnel, 
teachers, caregivers) (85.6%) and 29.4% of individuals were in usual contact with animals (mostly dogs and 
cats). Regarding clinical information, 68.2% of patients presented digestive symptoms at the time of stool 
analysis, 3.5% presented an immunosuppressed status and 6.5% were infected by other parasites. When 
comparing cases with controls in the multivariate analysis, variables associated to Blastocystis sp. infection 
were: being born in Africa (p=0.012, OR 5.216), having travelled abroad (p=0.004, OR 1.932) and working 
in direct contact with other people (p=0.004, OR 2.654). However, having an intestinal parasitic co-infection 
seems to have a protective value (p=0.046, OR 0.37). 
Conclusions. Significant risk factors detected in the present study include having an African origin, 
working directly with the public and recent travelling are risk factors for acquiring Blastocystis sp. infection. 
Our study provides new insights into the epidemiology of  Blastocystis sp. infection in industrialized countries, 
although larger and prospective studies must be performed. 
Keywords: Blastocystis hominis, Intestinal protozoa, Risk factors 
 
 
 
2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3  
1 Introduction 
 
Parasitic diseases contribute greatly to the burden of infectious diseases worldwide, being a cause 
of morbidity and mortality both in developed and developing countries [23]. Intestinal parasitic 
infections (IPIs) are a major public health problem in rural and urban environments of tropical of 
subtropical regions, with protozoan or helminths infections affecting about one third of the world’s 
population. Zoonotic diseases represent most of parasitic diseases distributed worldwide. Despite 
their huge animal, human and economic consequences, it has not been until recent years that there 
has been an increasing interest and concern by public health and veterinary authorities in human-
to-animal transmission of parasites [13, 22]. 
Nowadays, worldwide interconnections are rapidly increasing, leading to constant changes in 
ecosystems. This offers unpredictable opportunities to microbes, which are more varied, numerous, 
and adaptable than has ever been expected [13]. It is known that anthropogenic activity is affecting 
and accelerating natural climate change events, producing direct threatening effects on global health 
and security such as increases in temperatures and changes in weather patterns. It is suggested that 
these changes will likely increase the risk and incidence of infectious diseases [27]. Nonetheless, 
indirect consequences to these effects such as changes in parasitic diseases endemic ranges are not 
that easy to realize. Regarding parasitic diseases, tropical and subtropical regions are usually more 
affected because their warmer climates promote species richness. Moreover, usually, these are also 
areas with lower hygienic conditions. Changes in the environment may alter occurrence, prevalence 
and pathogenicity of parasites. Even though parasitic diseases are not a cause of high mortality rates, 
they can feed poverty in disadvantaged communities by debilitating and hampering their growth [59]. 
On the other hand, diarrhea and enteritis, which are typical symptoms of parasitic diseases infections, 
increase morbidity and produce significant economic losses in developed countries, such as those 
linked to medical and loss of productivity [55]. Blastocystis hominis distribution has been recently 
studied regarding climatic and socioeconomic conditions, and these have been suggested as factors 
that directly affect its prevalence [25, 31]. 
4  
Even being a big concern globally, zoonotic infectious diseases have a bigger impact in developing 
countries, where lifestyle is more dependent on animals. On the other hand, in developed countries 
bacterial and viral infection capture most of the attention and therefore, parasitic infections are 
usually downplayed. While enteric protozoa such as Entamoeba sp., Cryptosporidium, and Giardia 
are mostly found in developing countries, Blastocystis sp. and Dientamoeba fragilis are more 
frequent in developed countries [22, 23]. 
 
Blastocystis hominis 
 
History 
 
Blastocystis hominis is an enteric obligate anaerobic protozoan that resides in humans’ colon and 
cecum. It is the most common intestinal parasite isolated in humans, with up to 1 billion humans 
colonized or infected around the world, being developing countries the most affected ones [6,17,38], 
where prevalence can reach 100% of population [20].  Blastocystis hominis was discovered in  the 
early 1900s, however, little is known about its pathogenicity, genetic diversity, and available 
treatment options [16, 57]. From its discovery until recent days, its classification has ranged from a 
yeast to a fungus, but it was not until phylogenetic analysis were done that it was finally positioned 
as the only known zoonotic Stramenophile [66]. The fact that it does not present the typical features 
of this group is useful to understand how difficult it has been to classify it correctly [62]. 
 
Morphology 
 
Blastocystis hominis presents different life-cycle stages, so its size varies from 5 to 40 µm (Fig. 
1). It reproduces asexually, usually by binary fission [60]. Four main stages have been described, 
including amoeboid, vacuolar, granular and cystic. However, these have been reported to be mainly 
indistinguishable under the microscope [66]. Vacuolar form is a multinucleated stage that presents 
a large and central vacuole that occupies around 90% of the cell’s volume. The amoeboid form, 
which is rarely reported in stool samples, presents pseudopod-like cytoplasmic extensions even 
though it appears to be nonmotile. The granular form is a multinucleated stage that presents a 
central vacuole surrounded by granules. Cysts, which are the most frequent stage, have a rounded 
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shape and are protected by a multilayered cyst wall, which can and cannot be covered by a loose 
surface coat [66]. Avacuolar and multivacuolar cells and cells containing filament-like inclusions 
have also been described but appear to be less frequent. These are rarely seen in stool samples [50]. 
 
Figure 1: Stool sample with Blastocystis hominis. Detection was performed  by  microscopic  examination 
of stool samples following concentration using the Blagg’s concentration technique (merthiolate-iodine-
formaldehyde concentration). 40x field microscopy. Image obtained from the Microbiology department 
from the Vall d’Hebron University Hospital. 
 
 
Life cycle 
 
Blastocystis hominis is commonly found in stools from humans and a wide range of animals, 
including mammals, birds and amphibians [54]. Transmission has been stated to occur from human 
to human,  human to animal or animal to human [50, 61].  By now,  only chickens and  rats have 
been demonstrated to be suitable experimental models for Blastocystis hominis [30],  but the lack 
of a reliable animal model for this infection complicates further investigation of its pathogenesis 
[15, 30, 67]. Furthermore, the non-standardization of diagnostic techniques, high genetic diversity 
and studies with small size samples lead to current controversies surrounding Blastocystis [66]. 
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Humans and animals are externally infected by fecal cysts, which, after ingestion pass down the 
intestinal tract and undergo a change by blending cytoplasmic vesicles into a vacuole in the large 
intestines [22] (Fig. 2). The vacuolar form can reproduce by binary fission and may change to an 
amoeboid or granular form or may form a cyst in the host’s lumen. In the host intestine, vacuolar 
form will encyst and create a fibrillar layer, that will be lost before getting to the external 
environment again. The transition from the vacuolar to the amoeboid form reflects the progression 
from an asymptomatic to a symptomatic stage [58]. However, transition from amoeboid to vacuolar 
form, and from vacuolar to cyst form is not fully understood. Whereas the amoeboid form is mostly 
associated with pathogenicity, cysts are the only infective and transmissible form [73], and are likely 
to be excreted in faeces, restarting the infective cycle. There are two types of cysts: thin walled, 
which contain schizonts and allow auto-infection, and thick walled, which are responsible for the 
external transmission [10]. As cysts are highly resistant to the environment conditions and can 
survive outside the host for more than 1 or 2 months in water at 25oC or 4oC, respectively, they are 
mainly involved in external transmission. However, they are fragile at extreme temperatures and in 
common disinfectants [50, 60, 66]. 
Figure 2: Proposed life cycle for Blastocystis hominis. Extracted from [54] 
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Genetic diversity 
 
Recent studies based on the comparison of the nuclear small subunit rRNA gene show that 
Blastocystis has an extensive molecular diversity. Up to 17 genetic distinct ribosomal lineages have 
been described, and 5 more have been recently suggested [32], being subtypes (STs) 1-9, specially 
ST3 [2, 50], the most found in human epidemiological studies [54]. In addition, STs 1-8 and 12 are 
shared both by humans and animals, suggesting that animals may be reservoirs for Blastocystis and 
may be involved in zoonotic transmission. Amongst these, ST1 is considered the most virulent. [50]. 
ST8 has been found in zookeepers working with non-human primates [1], as well as pig workers 
were infected with ST5 in South East Queensland, Australia [69]. In spite of this, STs 1-4 are more 
common in humans, appearing in 90% of isolations, rather than STs 5-8, which are usually found in 
hoofed animals (ST5), birds (STs 6 and 7) and in non-human primates (ST8). At this moment, ST 9 
is the only one known to be restricted to humans [62], whereas STs 10, 11, 13-17 have only been 
detected in animals [37]. 
Prevalence and proportion of STs is known to vary across the world. For example, a recent study 
found that ST4 is very common in Europe and the United States whereas ST2 mainly predominates 
in non-industrialized populations [8]. However, any clear explanation has been found to this fact. 
Different epidemiological and demographic characteristics such as climate, geography, cultural 
habits, exposure to reservoir hosts and way of transmission are the reflection of the differences in 
diversity and prevalence of STs isolated from humans [2]. 
 
Epidemiology 
 
Blastocystis distribution around the world is not homogeneous, as prevalence can vary from  up 
to 10% in developed countries to 50-60% in developing countries [44]. This large variance may be 
due to miss-reporting and miss-detection in some clinical laboratories, what suggests that 
prevalence may be higher than recorded in some studies [28]. The high prevalence in developing 
countries is usually related to poor hygiene practices and to consumption of contaminated food or 
water [9]. Therefore, Blastocystis rate may be a reflect of the sanitation conditions of a population. 
In addition, recent studies have also strongly related its distribution to the socioeconomic and 
geographic situation [31]. However, developed countries also show high prevalence rates of 
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infection. Animals have been suggested as the sources of infection since genetic similarity has 
been demonstrated [31]. Immigrants, travelers and people who live in close contact with animals 
are also susceptible to suffer B. hominis infection. Prevalence does not only vary from one country 
to another, but it may also change between regions from the same country [10, 15]. Even so, it has 
been shown that in developing countries, infection still affects more lower socio-economic status 
communities [60]. Furthermore, factors such as climate have been shown to have an effect on 
Blastocystis prevalence [31]. 
 
Pathogenesis 
 
Nowadays, there is a growing recognition about B. hominis pathogenic potential, although its 
virulence mechanisms are not fully understood [6]. Illness can be either acute or chronic if the 
parasite accommodates in the human gastrointestinal system, with symptoms persisting from weeks 
to years [10, 11]. However, no consensus has been reached yet, and many authors still put on doubt 
Blastocystis role in human disease [12, 35, 43, 60]. Even so, it is accepted to be a potential pathogen 
for immunocompromised people. Pathogenicity has been suggested to be subtype dependent, being 
STs 1,4 and 7 the most pathogenic ones, and STs 2 and 3 nonpathogenic [22, 67]. Moreover, it has 
also been related to intensity and host immunity [50]. 
Transmission is mostly accepted to happen feco-orally both by direct or indirect ways, like 
contact with infected people or animals or through the ingestion of contaminated water, respectively. 
Food-borne transmission has also been reported as a source of infection [9, 21]. Due to its 
controversial pathogenicity -it can be found both in symptomatic and asymptomatic patients-,   the 
role of Blastocystis sp. as a truly pathogen or as a commensal organism has been widely debated, and 
its real human health impact is still uncertain [19]. The different behavior shown could be 
associated with the high genetic diversity found in this species [5]. However, and even it is usually 
an asymptomatic parasite, it is thought to cause nonspecific gastrointestinal symptoms including, 
diarrhea, abdominal pain, flatulence, dyspepsia or vomiting [9]. Moreover, cutaneous manifestations 
such as chronic urticaria have been reported as well as it has been associated to blastocystosis, 
especially in patients with irritable bowel syndrome (IBS) [57, 63, 70]. 
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Risk factors 
 
Factors affecting prevalence of intestinal parasites may vary between countries according to 
geographical and climate conditions of the area, sociocultural characteristics, nutrition culture, 
poverty, malnutrition, basic sanitary conditions and population density [28,41,42]. There are several 
risk factors that have already been described. Some of them, such as close contact with domestic 
animals and livestock, gender, age, work place, seasonality, region of location, immunocompromised 
status and diabetes may be shared both by developed and developing countries. However, whereas 
overcrowding, poor personal and environmental hygiene, lack of safe water supply and poor 
sewerage and waste removal services may be determinant factors in developing countries, this may 
not be crucial in the developed ones. On the other hand, travelling to tropical and under-developed 
countries, specially to tropical and subtropical ones, may have a higher importance in developed 
countries [60]. 
Data regarding gender is inconclusive, as both females and males have been identified as a 
potential risk factor by different studies [45, 51]. On the other hand, some authors have  not  found 
any correlation between infection and gender [10]. Differences and divisions in men and women 
type of work performed together with environmental, ecological, economic and cultural factors 
may affect the risk of infection. In countries where the rift between genders is bigger education 
opportunity, nutritional status and access to medical facilities may even have a bigger importance 
[24]. Regarding age groups, children have been sometimes related to a higher risk to get infected 
by Blastocystis sp., even though it may be acquired in subsequent years [62]. Reasons for relate it 
to children include the lack of natural resistance and differences in behaviors and habits [52]. 
Prevalences as high as 100% were found in children from a Senegalese community [20]. However, 
other studies found older age groups to be more prevalent [65] whereas others found no differences 
between age groups [55]. Therefore, no consensus has been reached regarding age. 
A recent study was the first to show the strong effects that Human Development Index (HDI), 
an indicator name by the United Nations (UN), has on the prevalence of Blastocystis [31]. HDI is 
used to rank countries depending on income, quality and expectancy of life and education. 
Socioeconomic factors such as water quality, contact with animals and sanitary conditions have 
been related with Blastocystis prevalence [4]. Given the viability and resistance of cysts to water, it 
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has been demonstrated to be a possible source for Blastocystis transmission [18]. Consumption of 
untreated or unboiled water has also been related to a higher risk of getting Blastocystis infection [36]. 
If water treatment has not been performed correctly it can still contain infectious parasite forms. 
Even so, developed countries do not usually consider water-borne transmission as a reason for 
disease, however, parasites may both be transmitted by water in both developed and developing 
countries [14, 22]. Moreover, improper hygienic conditions facilitate Blastocystis transmission [53]. 
In addition, Blastocystis infection has sometimes been associated to other parasites, including 
Trichomonas hominis, Giardia lamblia, Entamoeba histolytica and Dientamoeba fragilis [15, 36] 
It has been demonstrated that people who are in close contact with animals are at a higher risk to 
be infected with Blastocystis [56], what reinforces the hypothesis that it is a zoonotic infection [15]. 
Therefore, those occupations that involve exposure to animals are also at a higher risk to suffer 
infections by this parasite [66] Amongst pets, dog ownership has been described as a potential risk 
factor to suffer the infection [9]. Regarding domestic farm animals, pigs’ potential as zoonotic 
reservoirs has also been demonstrated. In rural areas, education in personal hygiene and increase of 
sanitation facilities could help to decrease the prevalence of infections [72]. 
Seasonality has also been thought to be related to Blatocystis infection. A study performed in 
Spain found a higher peak of infection in adults during spring [26] whilst another study conducted 
in France found a higher peak in summer [19]. On the other hand, a study performed in the United 
States during year 2000, obtained a higher prevalence between August and October [3]. However, 
this data should be interpreted with caution, as seasonal differences between geographical location 
depend on a wide variety of factors rather than the season itself [26]. 
Patients with a history of recent travel (during the year before stool examination) to low-income 
countries have been reported to have a higher prevalence of infection [7]. In addition, a study 
detected that individuals who had travelled more than once to countries at risk in the previous year 
had even a higher prevalence [19]. 
An immunocompromised state has also been related to a higher risk to get infected by Blastocystis, 
what may be a threaten for these patients [45].  HIV-positive  population has been stated to have  a 
higher prevalence of infection [48]. Moreover, digestive disorders are more frequent amongst this 
population group [19]. Some authors have stated Blastocystis implication in irritable bowel 
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syndrome (IBS) [50, 62, 71], whereas others have refused it [61, 68]. However, the number of 
patients in the latter may have been too low to show any difference, as only 84 patients participated, 
of which just 25 where controls. Higher levels of IgG2 sub-class of antibodies against Blastocystis 
hominis have been detected in patients with IBS [60]. A recent study demonstrated that patients 
with diabetes mellitus are at a higher risk to suffer parasitic infections [45]. In addition, amongst all 
infections, Blastocystis’ was the highest detected. 
 
Diagnosis 
 
Diagnosis is usually made through observation of characteristic form of the parasites in fecal 
samples. Microscopic methods usually stain Blastocystis with trichrome. However, these techniques 
have low sensitivity and may present false-negative results. Cultivation are less sensitive than 
microscopic methods when detecting Blastocystis. However, these are usually time-consuming 
methods (2-3 days). PCR detection of the small-subunit ribosomal RNA (SSU rRNA) gene is a 
powerful method, which is little by little getting widely used for detecting enteric parasites. It 
provides not only a higher sensitivity than the methods commented before but a higher specificity 
for detecting the organism’s DNA too [50]. Nevertheless, the lack of recognition of different 
morphological forms of the parasite causes misinterpretation and may lead to different prevalences 
depending on the detection method used. It has been demonstrated that direct-light microscopy  or 
in vitro cultures are less sensitive than qPCR, which has a higher sensitivity specificity, being able 
to detect all forms of Blastocystis parasites [20, 49]. Even so, molecular methods are more 
expensive and are not affordable in some countries [39]. 
 
Treatment 
 
Both controversy on the pathogenesis and the non-standardization of a diagnostic criteria difficult 
finding a consensus within the treatment [43]. Metronidazole is normally the first-line drug used for 
treatment and eradication, presumably causing Blastocystis apoptosis. However, its effectiveness is 
not been clearly stated, obtaining eradication rates as low as 0% [46, 54] and as high as 100% [64], 
so there is yet no agreement for what treatment to use nor when to offer it [15, 34, 60]. However, 
in asymptomatic patients, treatment is not usually indicated [15]. Resistance to metronidazole 
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has been suggested to explain metronidazole failure in completing eradication of Blastocystis in 
some patients, particularly those with severe infections [58]. The most common alternative to it is 
trimethoprim/sulfamethoxazole (TMP-SMX), but limited efficacy has also been reported. Other 
treatments include emetine dihydrochloride, furazolidone, iodoquinol, which have been shown to 
have and inhibitory effect on Blastocystis hominis growth in vitro [60]. Even so, the use and 
combination of these has not been demonstrated to be effective neither [46]. So, to treat Blastocystis 
infection, metronidazole and TMP/SMX are clearly effective for some individuals, but not for all. 
Some of them may not even need any treatment to get rid of the parasite, as happened in a study 
conducted in Northern Taiwan [33]. However, reasons for these differences are not known yet [43]. 
 
 
2 Justification and Objectives 
 
Throughout these lines, it has been stated that the public health burden of Blastocystis sp.  is still 
under-estimated, and so the interest in performing large-scale epidemiological surveys in 
industrialized countries. Parasitological studies in developed countries are not common. In Spain, 
studies regarding B. hominis infection are limited [26, 47, 57] focus on specific populations groups 
and are out of date [40]. Furthermore, we have highlighted the importance that emerging zoonoses 
are acquiring nowadays not only because animals and humans are affected, but because it creates an 
economical burden both in developed and developing countries. 
Despite all the efforts done by numerous researchers, especially in closer years, Blastocystis is 
still surrounded by controversy. But, what does make Blastocystis such a moot organism? Some 
reasons for Blastocystis being the most common parasite isolated in human may refer to a low 
pathogenicity and unprecise symptomatology that make physicians not to treat it habitually. The 
main controversy is its role as a pathogen [61]. A wide genetic diversity, small sample sizes as well 
as the non-standardization of detection techniques may lead to data misinterpretation [66, 67]. The 
fact that no animal model has been found, makes it difficult to demonstrate experimentally the 
pathogenic potential of Blastocystis [29]. Regarding treatments, large randomized controlled 
clinical treatment trials are also missing, and those existing present discrepant results [15]. The 
large number of drugs available with a wide efficacy variety contributes to the difficulty to assess 
infected individuals. [64]. Moreover, ST and sensitivity to drugs are thought to be related, with 
specific subtypes unsusceptible to metronidazole [54, 58, 64]. 
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Therefore, the main objective of the present study was to determine the risk factors associated 
to Blastocysitis hominis infection. The independent variables studied were those that have been 
associated with risk of Blastocystis hominis infection i.e. age, gender, country of origin, and time 
living in Spain (in case the patient was born in another country), seasonality, residence location, 
contact with animals, travelling out of Spain the year before to the stool examination, digestive 
symptoms when the coproparasitological examination was done, diabetes mellitus and 
immunosuppression status. 
 
 
3 Material and Methods 
 
Study design 
 
A retrospective case and controls study was performed at the Vall d’Hebron University Hospital, 
a tertiary hospital included in the International Health Program of the Catalan Health Institute 
(PROSICS, Barcelona, Spain). 
 
Ethical issues 
 
Prior to data collection, the study protocol was reviewed and approved by the Ethics Committee 
of the Vall d’Hebron University Hospital. 
 
Study size 
 
Epidat 4.2 non-lucrative project was used to select the study cohort. A proportion of exposed 
cases of 50% was selected i. e. those infected by B. hominis. On the other hand, a proportion of 
35% was agreed for exposed controls i. e. those who were not infected. Moreover, one control was 
assigned to every case with an Odds Ratio (OR) established at 1,857. The power of the study was 
established at 80% with a confidence level of 95%. With the previous data, a sample size of 170 
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cases and 170 controls was obtained, which were selected among hospital patients by means of a 
randomized selection. 
 
Subjects 
 
The Vall d’Hebron University Hospital (Barcelona, Spain) receives all microbiological tests 
performed in Barcelona at primary care level. After consulting the Microbiology Department 
registry, 34.158 stool samples from all patients that were analyzed at the hospital from January to 
December 2017 were selected. Those from patients younger than 18 years old when study was 
performed, who had not been practiced only 3 coproparasitological examinations or who had been 
given a previous treatment, were discarded. Only patients with 3 stool samples were selected 
because of an agreement with earlier studies that state the need for multiple stool examinations with 
microscopy before reporting a negative result for Blastocystis [7]. 12.522 samples remained, which 
corresponds to 4.174 patients. From this, 1.928 (15,4%) were infected with Blastocystis hominis 
(Fig 3). 
 
Figure 3: Flow diagram depicting study cohort size and selection 
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Questionnaire 
 
Based on reviews of the literature on intestinal parasitic infections, we developed a standardized 
questionnaire to determine the demographic and clinical characteristics of patients, in order to be 
able to later assess the correlation between the questionnaire’s answers and potential infection risk 
factors (Fig. 4) [57, 60, 62, 63, 70]. It included questions regarding date of inclusion, age, sex, 
origin, type of work, type of environment, travels, regular contact with animals and gastrointestinal 
symptoms. The questionnaire also included questions about clinical issues such as number of 
positive stools, diabetes mellitus, immunosuppression and co-infection with other parasites, which 
were obtained by looking at the medical record of patients. Factors related to hygiene and quality of 
water were not included in the questionnaire given their lower impact in developed countries. All 
questions were asked related to the moment of the stool sampling. As it has been demonstrated that 
Blastocystis can persist for months and colonize the gut [8], questions referring to previous travels 
took into account those done between year 2016 until the time when stool sampling was done. 
 
Data collection 
 
 Eligible patients were contacted by telephone and, after a brief description of our research, they 
gave their consent to answer the questionnaire and use their data for a scientific purpose and to elicit 
their medical record. Contact telephones were obtained from the electronic medical record (EMR) 
at our institution. Patients were called at the most three times before passing to another randomized 
patient. Amongst cases, 259 patients were contacted until gathering 170 responses. On the other 
hand, among controls, 263 individuals had to be contacted. 
 
Statistical analysis 
 
IBM SPSS software platform version 15 was used to perform the statistical analysis. Categorical 
data were presented as absolute numbers and proportions, and continuous variables were expressed 
as means and standard deviations (SD) or medians and interquartile ranges (IQR) depending on 
the distribution. The Kolmogorov-Smirnov test was used to evaluate the normal distribution of 
variables. The χ2 test or Fisher exact test, when appropriate, was used to compare the distribution of 
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categorical variables, and the t-Student test for continuous variables. Multivariate logistic regression 
analysis was made to identify factors associated with Blastocystis hominis infection. Variables 
were entered in the model if p<0.20 on univariate analysis. Results were considered statistically 
significant if the 2-tailed P value was <0.05. 
 
 
4 Results 
 
Overall demographic profiles 
 
The epidemiological characteristics of patients are summarized in Table 1. A total of 340 
individuals aged 17 to 88 were interviewed in this study with an overall median age of 46.7 ± 
18.24 years, most of them females (n=206, 60.6%). Most of the participants lived in Barcelona city 
(n=326, 95.9%), whereas the rest lived mainly in the surrounding areas. 126 (37.1%) of participants 
were immigrants and had been living in Spain, on average, 11 years. Among them, the majority of 
immigrants came from America, encompassing 69 (20.3%) patients. Specifically, 54 (15.9%) came 
from South America, 14 (4.1%) from Central America and 1 (0.3%) from North America. 24 (7.1%) 
immigrants came from Asiatic countries, and 16 (6.96%) from European countries. Finally, 17 (5%) 
patients came from Africa. 
Jobs were subdivided into two categories, depending on the presence of direct contact with other 
people or not. Hospital personnel, teachers, restaurant workers and caregivers were included in this 
group. Nevertheless, most of the people did not work with the public (n=291, 85.6%).  Only 4 
(1.2%) people were in contact with the rural. Regarding daily life, 100 (29.4%) patients were in 
usual contact with animals, 70 (20.6%) of them with dogs and 28 (8.2%) with cats. Other pets 
included birds (n=6, 1.8%), rabbits (n=7, 2.1%), turtles (n=2, 0.6%), fishes (n=1, 0.3%), hamsters 
(n=3, 0.3%) and chickens (n=3, 0.3%). Summer was clearly the season with the highest prevalence, 
with 122 (35.9%) samples collected during those months. It was followed by 86 (25.3%) samples on 
autumn, 67 (19.7%) in winter and 65 (19.1%) in spring. In addition, 171 (50.3%) patients travelled 
out of Spain during the year before the stool sampling. The most visited continent was Europe, with 
66 (19.4%) individuals, followed by 62 (18.9%) visitors to America and 34 (10%) to Asia. 
17  
Cases demographic profiles 
 
Among the 170 Blastocystis hominis positive individuals, age ranged from 18-85, with a median 
age of 43.95 ± 17.9 years. 98 (57.6%) participants were females, and Blastocystis was mostly found 
in the three of the stools (141/170). Urban environment predominated amongst participants (n=169, 
99.4%), who were mainly born in Spain (n=93, 54.7%). Nevertheless, the 77 (45.3%) immigrant 
Blastocystis positive patients, had been living in the country 11 years on average. Regarding their 
birth place, America was the country with the highest percentage of individuals, with 42 (20.3%) of 
them. Specifically, 30 (17.6%) had been born in South America, 11 (6.5%) in Central America and 
only 1 (0.58%) in North America. 14 (8.2%) participants were born in Africa, 13 (7.6%) in Asia 
and 8 (4.7%) in other European countries apart from Spain. 
Jobs with no regular contact with people predominated, with 137 (80.6%) people working on 
them. Only 47 (27.6%) people had regular contact with animals, 31 (18.2%) of them with a dog, 13 
(7.6%) with a cat and the 11 remaining with birds (n=6, 1.8%), rabbits (n=4, 2.4%), chickens (n=1, 
0.6%), fishes (n=1, 0.6%), turtles (n=1, 0.6%) or hamsters (n=1, 0.6%). 66 (38.8%) patients were 
diagnosed in summer, whereas only 31 (18.24%) were during winter. During spring and autumn, 
a similar number of samples were collected (21.76% and 24.17%, respectively). European and 
American countries were both visited by 36 (21.2%) people. From these, Southern Americans were 
the most visited, with 24 (14.1%) people, followed by North and Central American countries, each 
of them with 6 (3.5%) travelers. 
 
Controls demographic profiles 
 
On the other hand, the 170 Blastocystis hominis negative individuals were aged 17-88, with an 
average of 49.44 ± 18.2 years, with women also being the prevalent population (n=108, 63.5%). 
Only 3 (1.8%) people lived in a rural environment.  The average of time living in Spain for the 49 
(28.8%) immigrants was of 11 years, and they mostly came from American countries (n=27, 
15.9%). From these, 24 (14.1%) were from South America, 3 (1.8%) from Central America and 
none from the northern part. 
153 (90%) people had no regular contact with others at work, whereas 16 (9.4%) worked directly
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with public and only 1 (0.6%) had contact with the rural. Regarding pets, 53 (31.2%) people was in 
possession of them. 39 (22.9%) people had a dog whereas 15 (8.8%) had a cat. The remaining 9 
(5.8%) had birds (n=3, 1,8%) or rabbits (n=3, 1,8%), hamsters (n=2, 1.2%) or turtles (n=1, 0.6%). 
Summer was again the most prevalent season for stool examination, with 56 (32.93%) samples, 
followed by autumn with 50 (29.4%), winter with 36 (21.2%) and spring with 28 (16.5%). 99 
(58.2%) people travelled out of Spain amongst negative population for Blastocystis. 30 (17.6%) 
people visited Europe. 
 Table 1: Univariate and multivariate analysis for epidemiological characteristics of patients with and without Blastocystis sp. infection attended in 
Barcelona (2017). Data are reported as number of patients (%) or median (range). Abbreviations: BH+, Blastocystis hominis positive patients; BH-, 
Blastocystis hominis negative patients. 
 
 
 
Characteristics Overall BH+ BH- Univariate analysis Multivariate analysis 
 (n = 340) (n = 170) (n = 170) P value (OR, 95%CI, and P value) 
Age, years 46.69 (17-88) 43.95 (18-85) 49.44 (17-88) 0.005 OR 0.994 (0.98-1.008) p=0.396 
Gender, female 206 (60.6%) 98 (57.6%) 108 (63.5%) 0.267  
Origin      
Immigrant 126 (37.1%) 77 (45.3%) 49 (28.8%) 0.002 OR 1.301 (0.753 - 2.2251), p=0.346 
Spanish 214 (62.9%) 93 (54.70%) 121 (71.2%)   
Immigrant’s origin continent 
North America 1 (0.3%) 1 (0.58%) 0 (0%) 0.317  
Central America 14 (4.1%) 11 (6.5%) 3 (1.8%) 0.029 OR 3.418 (0.881-13.256), p=0.075 
South America 54 (15.9%) 30 (17.6%) 24 (14.1%) 0.373  
Africa 17 (5%) 14 (8.2%) 3 (1.8%) 0.006 OR 5.216 (1.441-18.879), p=0.012 
Asia 24 (7.1%) 13 (7.6%) 11 (6.5%) 0.672  
Other European countries 16 (6.96%) 8 (4.7%) 8 (4.7%) 1.000  
Travelling 171 (50.3%) 99 (58.2%) 72 (42.4%) 0.003 OR 1.932 (1.229-3.037) p=0.004 
North America 10 (2.9%) 6 (3.5%) 4 (2.4%) 0.521  
Central America 13 (3.8%) 6 (3.5%) 7 (4.1%) 0.777  
South America 39 (11.5%) 24 (14.1%) 15 (8.8%) 0.126 OR 1.692 (0.790-3.624) p=0.176 
Africa 24 (7.1%) 17 (10%) 7 (4.1%) 0.034 OR 1.346 (0.438-4.131) p=0.604 
Asia 34 (10%) 20 (11.8%) 14 (8.2%) 0.278  
Europe 66 (19.4%) 36 (21.2%) 30 (17.6%) 0.411  
     [Continues in the following page] 
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Characteristics Overall BH+ BH- Univariate analysis Multivariate analysis 
 (n = 340) (n = 170) (n = 170) P value (OR, 95%CI, and P value) 
Type of work 
Contact with people 
 
49 (14.4%) 
 
33 (19.4%) 
 
16 (9.4%) 
 
0.009 
 
OR 2.654 (1.356-5.197), p=0.004 
No contact with people 291 (85.6%) 137 (80.6%) 154 (90%)   
Contact with animals 100 (29.4%) 47 (27.6%) 53 (31.2%) 0.475  
Dog 70 (20.6%) 31 (18.2%) 39 (22.9%) 0.283  
Cat 28 (8.2%) 13 (7.6%) 15 (8.8%) 0.693  
Bird 6 (1.8%) 3 (1.8%) 3 (1.8%)   
Rabbit 7 (2.1%) 4 (2.4%) 3 (1.8%)   
Chicken 1 (0.3%) 1 (0.6%) 0 (0%)   
Fish 1 (0.3%) 1 (0.6%) 0 (0%)   
Turtle 2 (0.6%) 1 (0.6%) 1 (0.6%)   
Hamster 3 (0.9%) 1 (0.6%) 2 (1.2%)   
1
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Overall clinical characteristics 
 
Clinical characteristics of patients are summarized in Table 2 Most of the patients presented 
diverse digestive symptoms (n=232, 68.2%), and only 22 (6.5%) of participants were co-infected 
with other organisms, mainly Endolimax nana (n=9, 2.6%) and Giardia lamblia (n=6, 1.8%). 
Others include Dientamoeba fragilis (n=4, 1.2%), Entamoeba coli (n=3, 0.9%) and Entamoeba 
histolytica/E. dispar (n=3, 0.9%), Strongyloides stercoralis (n=2, 0.6%) and Enterobius vermicularis 
(n=1, 0.3%). 25 (7.4%) patients were diabetic and 12 (3.5%) presented an immunocompromised 
status. Amongst immunosuppressions, most patients were HIV positive (n=6, 1.8%). There were 
14 patients (4.1%) with a diagnosis of irritable bowel syndrome. 
 
Cases clinical profiles 
 
Regarding Blastocystis positive patients, 116 (68.2%) presented digestive symptoms, and only 7 
(4.1%) were co-infected with other parasites. Among parasitosis, Endolimax nana predominated, 
with 5 (2.9%) people infected. Giardia lamblia (n=1, 0.6%), Dientamoeba fragilis (n=2, 1.2%), 
Entamoeba coli (n=2, 1.2%) and Entamoeba histolytica/E. dispar (n=1, 0.6%) were also found 
among stool samples. 9 (5.3%) patients were diabetic, and 6 (6.5%) individuals presented and 
immunocompromised status and only 4 (2.4%) had irritable bowel syndrome. 
 
Controls clinical profiles 
 
When it comes to Bastocystis negative patients, also 116 (68.2%) patients had digestive symptoms, 
and 15 (8.8%) presented other parasites. Giardia lamblia was the most found among these, infecting 
5 (2.9%) people. Endolimax nana was also found in the samples, and infected 4 (2.4%) people. Other 
parasites found were Dientamoeba fragilis (n=2, 1.2%), Entamoeba coli (n=1, 0.6%), Entamoeba 
histolytica/E. dispar (n=2, 1.2%), Strongyloides stercoralis (n=2, 1.2%) and Enterobius vermicularis 
(n=1, (0.6%). Lastly, 10 (5.9%) people presented irritable bowel syndrome. 
21  
Univariate statistical analysis 
 
Age, immigration, coming from Africa or Central America, working with the public and travelling, 
specifically to Africa or South America were statistically significant for the univariate analysis 
(P<0.05). Blastocystis hominis positive patients were younger (median age 43.95 years vs 49.44 
years, P = 0.005) and included a larger proportion of immigrants (45.3% vs 28.8%, P = 0.002), 
people who worked directly with public (33 vs 16, P = 0.009) and individuals who had travelled 
out of Spain (58.2% vs 42.4%, P = 0.03). When it comes to immigrants, those coming from Central 
America or Africa were also found to be significant (P = 0.029 and P = 0.006, respectively). 
Regarding travelling, only Africa was found to be a statistically significant (P = 0.034) continent. 
Seasonality was also considered in the analysis in order to know if differences in the number of 
samples during the year were statistically significant, but no correlation was obtained (P = 0.194). 
 
Multivariate statistical analysis 
 
After doing the multivariate analysis, the variables associated to suffer Blastocystis hominis 
infection were coming from Africa or Central America, having travelled out of Spain and working 
with the public. Moreover, being infected by other parasites resulted to be a protective factor. 
Having an African origin was the most strongly correlated factor, with an OR of 5.216 (95%CI, 
1.441-18.879), p=0.012). Moreover, working directly with public was also strong associated factor, 
with and OR of 2.654 (95%CI, 1.356-5.197, p=0.004). Travelling out of Spain was also related 
Blastocystis hominis infection, with an OR of 1.932 (95%CI, 1.229-3.037, p=0.004). Finally, being 
infected with other parasites was found to be a protective factor, with an OR 0.370 (95%CI, (0.14-
0.98), p=0.046). 
 Table 2: Univariate and multivariate analysis for clinical characteristics of patients with and without Blastocystis sp. infection attended in Barcelona 
(2017). Data are reported as number of patients (%) or median (range). Abbreviations: BH+, Blastocystis hominis positive patients; BH-, Blastocystis 
hominis negative patients. 
 
Characteristics Overall BH+ BH- Univariate Analysis Multivariate analysis 
 (n = 340) (n = 170) (n = 170) P value (OR, 95%CI, and P value) 
Presence of digestive symptoms 232 (68.2%) 116 (68.2%) 116 (68.2%) 1.000  
Other intestinal parasitosis 22 (6.5%) 7 (4.1%) 15 (8.8%) 0.078 OR 0.370 (0.14-0.98), p=0.046 
Emdolimax nana 9 (2.6%) 5 (2.9%) 4 (2.4%)   
Giardia lamblia 6 (1.8%) 1 (0.6%) 5 (2.9%)   
Dientamoeba fragilis 4 (1.2%) 2 (1.2%) 2 (1.2%)   
Entamoeba coli 3 (0.9%) 2 (1.2%) 1 (0.6%)   
Entamoeba histolytica/E. dispar 3 (0.9%) 1 (0.6%) 2 (1.2%)   
Strongyloides stercoralis 2 (0.6%) 0 (0%) 2 (1.2%)   
Enterobius vermicularis 1 (0.3%) 0 (0%) 1 (0.6%)   
Diabetes mellitus 25 (7.4%) 9 (5.3%) 16 (9.4%) 0.146 OR 0.586 (0.236-1.452) p=0.248 
Presumptive immunocompromised status 12 (3.5%) 6 (3.5%) 6 (3.5%) 1.000  
HIV 6 (1.8%)     
Crohn’s disease 2 (0.6%)     
Common variable immunodeficiency 1 (0.3%)     
Breast cancer 1 (0.3%)     
Hypogammaglobulinemia 1 (0.3%)     
Psoriasis 1 (0.3%)     
Irritable bowel syndrome 14 (4.1%) 4 (2.4%) 10 (5.9%) 0.101 OR 0.334 (0.98-1.137), p=0.079 
2
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5 Discussion 
 
Key results 
 
We retrospectively studied 340 patients, divided into cases and controls, whose stool samples 
were analyzed at the Vall d’Hebron University Hospital during year 2017. We used standardized 
questionnaires and medical records with the aim to gather information to detect risk factors related 
to Blastocystis hominis infection. Most of the samples were analyzed in summer (35.9%), and 
belonged to Spanish women (62.9% of individuals were Spanish, 60.6% were female and were 47 
years old, on average) who lived in Barcelona and did not work directly with the public (85.6% of 
participants did not have contact with people at work). The majority of participants (70.4%) did 
not have regular contact with animals. Among all the variables studied, we found out being African, 
working with the public and travelling to other countries to significantly increase the risk of getting 
infected by the parasite. Moreover, being infected by other parasites was found out to be a protective 
factor. 
Even having a worldwide distribution, developing countries are the most affected by intestinal 
parasitic infections [6]. Regarding our study, only people from Africa were reported to have a 
stronger risk of infection. A higher incidence, however, not significant, was also seen among people 
coming from Central America. Most immigrants had been living in Spain for 11 years, so no 
differences were established. 
A story of recent travel has been stated to be a risk factor to acquire this infection, being tropical 
and under-developed destinations those at increased risk of acquiring infection [15, 19]. A recent 
study from El Safadi et al. concluded that patients who had travelled during the last year before stool 
sampling were at higher risk than those who had not [19]. A similar conclusion can be extracted 
from our study since statistical significant data was obtained for the same variable. Among all 
possible destinations, Southern American and African countries had higher risk of infection, but it 
was not significant enough. It is interesting to point out that both immigrants coming from Africa 
and people travelling to Africa are both at a higher risk to get infected. However, the latter is not 
significantly important. 
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Seasonal distribution of Blastocystis hominis has been previously reported by some authors [19]. 
In our study, even though the number of samples gathered was higher in summer, we did not find 
significant differences in relation to the rest of the year. This agrees with other studies performed in 
the same geographical area [26, 57]. 
Age has sometimes been stated as a risk factor, usually describing children in developing countries 
as the most prevalent group, reaching 100% of infected population [20]. Children were not included 
in our study, but, even it was not statistically significant, younger adult age groups were at a higher 
risk than older, in accordance with a study conducted in France. However, it is important to highlight 
the fact that young people usually travels more, so this may increase the prevalence [19]. 
Some studies have associated Blastocystis infection to female gender [45], relating it to differences 
on the jobs, but also to environmental, ecological, economic and cultural factors [24]. In our case, 
women presented a higher prevalence of infection than men, but it was not statistically significant. 
Contact with animals has been stated to be a risk factor for Blastocystis infection [9, 51, 56], but 
not in our case. However, most of the studies which have proven this fact have been conducted in 
developing countries such as Thailand, The Philippines or Malaysia, where animal hygienic 
conditions and treatment may be different. In these studies, population is mostly rural and is in 
contact with livestock animals, whereas in our case dogs and cats were the main pets reported. 
The fact that the present study was conducted by using samples which had been analyzed at the 
Vall d’Hebron University Hospital, in Barcelona, conditioned the origin of our samples, so most 
people came from an urban environment.  Therefore, only 4 people out of 340 declared to live   in 
a rural environment. This finding made difficult to evaluate this variable and limits our study. 
Therefore, our results are based on an urbanized population, from an industrialized country. 
As Blastocystis infection has been stated to happen from human to human, participants job was 
divided into two groups, depending on their contact with other people or not [50]. Surprisingly, we 
found out that people working with other people were at a higher risk than those who did not. The 
majority of people who were at this group included caregivers, hospital personnel, restaurant 
workers and teachers. These occupations can be related to working with groups of people who are 
at a higher risk to get infected, meaning that the risk of those surrounding them may also be 
increased. Hospital personnel are usually in contact with immunocompromised people. Restaurant 
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workers are in constant contact with food, which has also been proved to be a possible source of 
transmission. Caregivers may be in contact with faeces from their guests, so feco-oral transmission, 
the main route, may happen [9]. Teachers spend most of their time in contact with children, whose 
age group has sometimes been noted to be at a higher risk [20]. Therefore, not taking the adequate 
prevention may increase significantly the risk of infection. Unfortunately, from all he participants 
almost no one worked in contact with animals or the rural (only 2 people did), so we cannot make 
any elucidation regarding this possible risk factor. 
Blastocystis hominis pathogenicity has been one of the main controversial issues regarding this 
parasite. It is nowadays thought to cause gastrointestinal symptoms. Even so, this was not a 
significant factor to take into account in our study. Curiously, the same number of participants among 
cases and controls reported presence of digestive symptoms. However, some studies suggest that 
pathogenicity may be related to different Blastocystis subtypes, and it has also been demonstrated 
that these subtypes vary along with geographical variation [2, 8]. 
Extensive research shows that immune suppression and the use of immunosuppressive drugs 
increases the risk of getting an infection [39,44,45]. However, in this study no correlation was found 
among these factors. Some studies have stated that [62] Blastocystis may be linked to irritable bowel 
syndrome (IBS). In our case, no significant differences were found. A study by Mohtashamipour 
et al. stated that diabetic patients are at a higher risk of getting a parasitic infection [45]. In this 
case-control study they also found out that Blastocystis hominis was significantly the most prevalent 
parasite. In our case, however, no differences were observed for this factor. A significantly lower 
prevalence of Blastocystis sp. was reported among patients who were infected by other parasites 
than those who were not. Enteric pathogens infection by different parasites has commonly been 
detected in recent studies [36, 47]. In our study, it has been found out to be protective factor. 
 
Limitations 
 
Given its retrospective nature, our study presents some limitations. Firstly, conventional 
microscopic methods, which have been stated to be less sensitive, were used for diagnosis rather 
than molecular methods [52]. Besides, the small sample size could also be a limiting factor, but the 
power of the study was high enough to show differences among cases and controls. Finally, some 
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people stated not to remember some of the issues asked during the questionnaire (mostly related to 
travelling or to the presence of digestive symptoms), what could suppose a bias for the results. 
 
 
6 Conclusions 
 
To summarize, a case and control study was conducted in the Vall d’Hebron University Hospital 
including 340 patients whose samples were collected during year 2017. The results of the present 
study suggest that African people, recent travelling, working with the public and co-infections with 
other intestinal parasites are risk factors for acquiring Blastocystis hominis infection. Our study 
provides new insights into the epidemiology of Blastocystis sp. in industrialized countries. Further 
research including molecular and epidemiological studies should be done. This would help to map 
prevalence and sub type distribution and to clarify the importance of risk factors depending on the 
area and would improve intervention strategies that could help to mitigate Blastocystis 
transmission. 
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Annex 
 
Standardized questionnaire 
 
 
Figure 4: Standardized questionnaire and observations from the medical record requested from all participants 
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